Statement Of Comprehensive Income [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183078

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	—	59,620,000 EUR	59,620,000 EUR	—	—	—	—	116,875,000 EUR	116,875,000 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, before tax [abstract]
Other comprehensive income, before tax, gains (losses) from investments in equity instruments	—	—	10,461,000 EUR	—	—	—	—	—	6,508,000 EUR	—
Components of other comprehensive income that will be reclassified to profit or loss, before tax [abstract]
Cash flow hedges [abstract]
Other comprehensive income, before tax, cash flow hedges	—	—	10,449,000 EUR	—	—	—	—	—	14,390,000 EUR	—
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss [abstract]
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss	—	—	2,612,000 EUR	—	—	—	—	—	3,597,000 EUR	—
Other comprehensive income	—	—	18,298,000 EUR	—	—	—	—	—	17,300,000 EUR	—
Comprehensive income	- EUR	18,298,000 EUR	77,918,000 EUR	59,620,000 EUR	- EUR	17,300,000 EUR	- EUR	- EUR	134,175,000 EUR	116,875,000 EUR
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	—	77,918,000 EUR	—	—	—	—	—	134,175,000 EUR	—
Comprehensive income, attributable to non-controlling interests	—	—	- EUR	—	—	—	—	—	- EUR	—